申请人:HOFFMANN LA ROCHE
公开号:WO2011070029A1
公开(公告)日:2011-06-16
This invention relates to 5,6-dihydro-4H-[1,3]oxazin-2-ylamine compounds of the formula (I) wherein R1 to R5 are as defined in the description and in the claims, as well as pharmaceutically acceptable salts thereof. These compounds are BACE2 inhibitors and can be used as medicaments for the treatment or prevention of diseases such as diabetes.
这项发明涉及式(I)的5,6-二氢-4H-[1,3]噁嗪-2-胺类化合物,其中R1至R5如描述和权利要求中定义的那样,以及其药用盐。这些化合物是BACE2抑制剂,可用作治疗或预防糖尿病等疾病的药物。